University of Oxford
KE Team of the Year Finalist: University of Oxford - Business Development and Partnering Team (Medical Sciences Division)
Over the last 8.5 years, the Business Development and Partnering Team within the Medical Sciences Division at Oxford has grown to 13 members and secured over £58M in industry investment through strategic partnerships. The team build and manage multi-year alliances with 14 companies; support major co-location initiatives with key strategic partners; foster a live pipeline of ~70 mature project development discussions, involving 35 companies and provide dedicated management of industry engagement for the NHS through close association with Oxford’s Biomedical Research Centre.
Some of the key relationships that the team have built, supported and enabled are with Novo Nordisk, Celgene, Bayer HealthCare, Elysium Health and Pfizer. Recently the introduction of a dedicated team member to develop our SME engagement strategy has been pivotal in utilising and creating new models to engage effectively with this set of unique companies.
We develop Fellowship schemes as a model for sustaining long-term engagement with international companies including UCB, Celgene, Novo Nordisk and Elysium, and have shared our experiences at international conferences. Additionally, to drive KE and networking we set up an Oxford Industry Fellows Network (over 50 Industry-sponsored Fellows and postdoctoral researchers) to offer opportunities for industry to train fellows, and for fellows to build their networks.
Our Experts in Residence scheme has driven KE in digital health (iWantGreatCare, IBM, Frog Design), surgical technologies (Koli Inc), med tech regulation (OrganOx), drug discovery and development (Evotech, GSK) and continues to grow.
As a large and disperse division with over 3000 researchers, size doesn’t always work to our advantage and can be a barrier to industry interaction. Our team successfully helps companies navigate the division and we have also found the balance between being visible, but also prioritising relationships where we can add most value.